Skip to content
value.today

Moderna, Inc. vs Poxel S.A.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $22 M for Poxel S.A., 4097 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Poxel S.A.). Poxel S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $7 M for Poxel S.A. in the year to December 2024.
  • Both made a net loss: $2.8 B for Moderna, Inc. and $20 M for Poxel S.A.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -275.9% for Poxel S.A.
  • Poxel S.A.'s revenue grew faster in its latest fiscal year: +235.5% against -39.9% for Moderna, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Moderna, Inc. 1370Poxel S.A. 6

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Moderna, Inc. $2BPoxel S.A. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureModerna, Inc.
MRNA · #274 in the world
Poxel S.A.
POXEL.PA
Profile
Country🇺🇸 USA🇫🇷 France
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded2010—
Size
Market cap$90.1 B$22 M*
Revenue$1.9 B$7 M
Net income$-2.8 B$-20 M▲ best
Employees4,700—
Valuation
Price to sales35.7×—
Price to book10.4×—
Free cash flow yield-2.3%—
Profitability
Gross margin55.4%55.7%▲ best
Operating margin-158.1%-52.8%▲ best
Net margin-145.2%▲ best-275.9%
Return on equity-28.9%—
Growth
Revenue growth-39.9%235.5%▲ best
Revenue growth, 3 years a year-53.4%—
Financial strength
Debt to equity0.1×—
Cash
Free cash flow margin-106.2%—
Shareholder returns
Shareholder yield0.0%—
Strength scores
Piotroski F-score3 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024; ratios FY2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Moderna, Inc. or Poxel S.A.?

Moderna, Inc. is the larger company by market value: $90.1 B against $22 M for Poxel S.A., 4097 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Poxel S.A.). Poxel S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Moderna, Inc. or Poxel S.A.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $7 M for Poxel S.A. in the year to December 2024. Both made a net loss: $2.8 B for Moderna, Inc. and $20 M for Poxel S.A.

Which is more profitable, Moderna, Inc. or Poxel S.A.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -275.9% for Poxel S.A.

Which is growing faster, Moderna, Inc. or Poxel S.A.?

Poxel S.A.'s revenue grew faster in its latest fiscal year: +235.5% against -39.9% for Moderna, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.